Godshall Douglas Evan's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Nov 16, 2022
- Accession no.
- 0001209191-22-057420
- Filed
- Nov 16, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.22M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-22-059519 (Dec 2, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Godshall Douglas EvanCIK 0001404227 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | SSaleDisposed | −900 | $235.72 | −$212,148 | 112,026 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −3,720 | $237.16 | −$882,235.2 | 108,306 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −2,642 | $238.01 | −$628,822.42 | 105,664 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −2,780 | $239.07 | −$664,614.6 | 102,884 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −1,482 | $240.07 | −$355,783.74 | 101,402 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −5,941 | $241.06 | −$1,432,137.46 | 95,461 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −2,710 | $242.12 | −$656,145.2 | 92,751 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −7,998 | $243.22 | −$1,945,273.56 | 84,753 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −1,027 | $243.79 | −$250,372.33 | 83,726 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −800 | $245.96 | −$196,768 | 82,926 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.